STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Cencora, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cencora, Inc. (COR)

To cover taxes on this vesting, 736 shares of common stock were withheld at a price of $362.07 per share. After these transactions, Campbell directly beneficially owned 27,242.141 shares of Cencora common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Campbell Elizabeth S

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 M 1,590 A (1) 27,978.141 D
Common Stock 11/20/2025 F(2) 736 D $362.07 27,242.141 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 11/20/2025 M 1,590 (1) (1) Common Stock 1,590 $0 3,180 D
Explanation of Responses:
1. Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027.
2. Satisfaction of tax withholding obligation incident to the vesting of restricted stock units.
Remarks:
/s/ Elizabeth S. Campbell 11/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cencora (COR) disclose in this Form 4 filing?

The filing reports that Executive Vice President Elizabeth S. Campbell had 1,590 restricted stock units convert into common shares on 11/20/2025, and some of those shares were used to satisfy tax withholding obligations.

How many Cencora (COR) restricted stock units vested for the executive?

A total of 1,590 restricted stock units vested and were converted into an equal number of Cencora common shares for Executive Vice President Elizabeth S. Campbell.

How were taxes handled on the Cencora (COR) RSU vesting?

To satisfy tax withholding obligations related to the vesting of restricted stock units, 736 shares of Cencora common stock were withheld at a price of $362.07 per share.

What is Elizabeth S. Campbell’s role at Cencora (COR)?

Elizabeth S. Campbell is an Executive Vice President of Cencora, Inc., as indicated in the relationship section of the Form 4.

How many Cencora (COR) shares does the executive own after these transactions?

Following the reported RSU conversion and tax withholding, Elizabeth S. Campbell beneficially owned 27,242.141 shares of Cencora common stock in direct ownership.

What are the vesting dates for the Cencora (COR) restricted stock units?

The restricted stock units were granted for no consideration and vest in three equal installments on 11/20/2025, 11/20/2026, and 11/20/2027, according to the explanation of responses.

Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.49B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN